At the end of this presentation, the participant will be able to:

• Understand the key radiobiological features of HDR dose fractionation
• Discuss the clinical implications of HDR fractionation on tumor and normal tissues in HDR brachytherapy
• Determine potential strategies to optimize HDR dose fractionation and therapeutic ratio